Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Clinical trial NCT04749563 · COMPLETED

Trial details

NCT number: NCT04749563
Sponsor: IGC Pharma, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dementia of Alzheimer Type

Start date: 2021-01-11
Primary completion: 2021-06-20
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.